Delivery Order SPE2DB22D2007-SPE2DB25FH7VX
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,322.65, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The order has an ultimate completion date of June 17, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation for this award. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,079.03, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract is a firm-fixed-price delivery order, with a period of performance ending on March 10, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a ceiling value of $9,815.74 and a completion date of June 18, 2024. It is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided about any major subcontractors. This delivery order is part of a larger Indefinite Delivery...
- This is a $3,441.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty pharmaceutical product, with a period of performance through July 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,348.61, is for the provision of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty medication. The contract is a Firm Fixed Price, Delivery Order with an ultimate completion date of January 30, 2025. This contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,947.55 contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The order has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,236.82, is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract is a firm fixed-price delivery order, without any set-aside designation, and has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,035.96, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 14, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,718.63, is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of July 17, 2024. AmerisourceBergen holds a significant Indefinite...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,911.89, is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract has a Firm Fixed Price pricing type and is set to expire on May 31, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation for this...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FH7VXDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,679.34, is for the provision of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract has a completion date of December 19, 2024 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation associated with this contract. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.7k | 12/18/24 |